David Claassen

452 total citations
10 papers, 346 citations indexed

About

David Claassen is a scholar working on Molecular Biology, Cell Biology and Genetics. According to data from OpenAlex, David Claassen has authored 10 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Cell Biology and 4 papers in Genetics. Recurrent topics in David Claassen's work include melanin and skin pigmentation (4 papers), Pluripotent Stem Cells Research (2 papers) and CRISPR and Genetic Engineering (2 papers). David Claassen is often cited by papers focused on melanin and skin pigmentation (4 papers), Pluripotent Stem Cells Research (2 papers) and CRISPR and Genetic Engineering (2 papers). David Claassen collaborates with scholars based in United States and Ireland. David Claassen's co-authors include Michelle Desler, Angie Rizzino, Marjan Huizing, James G. White, William A. Gahl, Paul Anderson, Robert S. Lahue, Richard A. Hess, Amanda Helip‐Wooley and Heidi Dorward and has published in prestigious journals such as SHILAP Revista de lepidopterología, Human Molecular Genetics and Human Genetics.

In The Last Decade

David Claassen

8 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Claassen United States 7 178 131 56 48 46 10 346
Sofia Nikou Greece 11 181 1.0× 67 0.5× 28 0.5× 27 0.6× 11 0.2× 22 320
Kaiju Jiang China 5 137 0.8× 169 1.3× 99 1.8× 7 0.1× 17 0.4× 7 375
Ekaterina Vasileva Switzerland 9 173 1.0× 118 0.9× 22 0.4× 16 0.3× 15 0.3× 12 318
F D'Anna Italy 8 117 0.7× 173 1.3× 38 0.7× 6 0.1× 22 0.5× 13 350
В. В. Терских Russia 11 193 1.1× 87 0.7× 29 0.5× 22 0.5× 3 0.1× 39 427
Bernd Thilo Dittrich Germany 7 211 1.2× 63 0.5× 65 1.2× 9 0.2× 8 0.2× 10 342
Maike Guschel Germany 8 149 0.8× 167 1.3× 20 0.4× 67 1.4× 3 0.1× 8 370
Karolien Van Den Bossche Belgium 5 153 0.9× 206 1.6× 29 0.5× 4 0.1× 66 1.4× 7 344
Anne‐Sophie Macé France 10 185 1.0× 124 0.9× 15 0.3× 13 0.3× 10 0.2× 17 299
Chiung-Ying Chang United States 8 399 2.2× 115 0.9× 70 1.3× 10 0.2× 13 0.3× 10 597

Countries citing papers authored by David Claassen

Since Specialization
Citations

This map shows the geographic impact of David Claassen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Claassen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Claassen more than expected).

Fields of papers citing papers by David Claassen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Claassen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Claassen. The network helps show where David Claassen may publish in the future.

Co-authorship network of co-authors of David Claassen

This figure shows the co-authorship network connecting the top 25 collaborators of David Claassen. A scholar is included among the top collaborators of David Claassen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Claassen. David Claassen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Sharathkumar, Anjali, David Claassen, Sergei Syrbu, et al.. (2024). Romiplostim for Treatment of Children and Young Adults With Severe Aplastic Anemia and Myelodysplastic Syndrome. Journal of Pediatric Hematology/Oncology. 46(5). 252–261.
2.
Sharathkumar, Anjali, et al.. (2022). Congenital Neutropenia with Specific Granulocyte Deficiency Caused by Novel Double Heterozygous SMARCD2 Mutations. SHILAP Revista de lepidopterología. 14(3). 270–275.
3.
Claassen, David, Kevin M. Bowling, Gregory M. Cooper, et al.. (2018). Complexities of genetic diagnosis illustrated by an atypical case of congenital hypoplastic anemia. Molecular Case Studies. 4(6). a003384–a003384. 10 indexed citations
4.
Claassen, David, Michelle Desler, & Angie Rizzino. (2009). ROCK inhibition enhances the recovery and growth of cryopreserved human embryonic stem cells and human induced pluripotent stem cells. Molecular Reproduction and Development. 76(8). 722–732. 135 indexed citations
5.
Cox, Jesse L., et al.. (2008). Regulation of the Nanog gene by both positive and negative cis‐regulatory elements in embryonal carcinoma cells and embryonic stem cells. Molecular Reproduction and Development. 76(2). 173–182. 6 indexed citations
6.
Claassen, David & Robert S. Lahue. (2007). Expansions of CAG{middle dot}CTG repeats in immortalized human astrocytes. Human Molecular Genetics. 16(24). 3088–3096. 32 indexed citations
7.
Claassen, David, et al.. (2005). Detection of hemizygosity in Hermansky - Pudlak syndrome by quantitative real-time PCR. Clinical Genetics. 68(1). 23–30. 6 indexed citations
8.
Huizing, Marjan, Richard A. Hess, Heidi Dorward, et al.. (2004). Cellular, Molecular and Clinical Characterization of Patients with Hermansky–Pudlak Syndrome Type 5. Traffic. 5(9). 711–722. 54 indexed citations
9.
Anderson, Paul, Marjan Huizing, David Claassen, James G. White, & William A. Gahl. (2003). Hermansky-Pudlak syndrome type 4 (HPS-4): clinical and molecular characteristics. Human Genetics. 113(1). 10–17. 100 indexed citations
10.
Huizing, Marjan, Amanda Helip‐Wooley, Heidi Dorward, et al.. (2003). IL-25 Hermansky-Pudlak syndrome: a model for abnormal vesicle formation and trafficking. Pigment Cell Research. 16(5). 584–584. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sofia Nikou Breakdown of academic impact, for papers by Kaiju Jiang Breakdown of academic impact, for papers by Ekaterina Vasileva Breakdown of academic impact, for papers by F D'Anna Breakdown of academic impact, for papers by В. В. Терских Breakdown of academic impact, for papers by Bernd Thilo Dittrich Breakdown of academic impact, for papers by Maike Guschel Breakdown of academic impact, for papers by Karolien Van Den Bossche Breakdown of academic impact, for papers by Anne‐Sophie Macé Breakdown of academic impact, for papers by Chiung-Ying Chang
Rankless by CCL
2026